申请人:Pfizer Inc.
公开号:US05641789A1
公开(公告)日:1997-06-24
Compounds of the formula ##STR1## and pharmaceutically acceptable salts and prodrugs thereof, wherein X.sup.1, Ar, X, Y.sup.1, R.sup.1, R.sup.2, R.sup.3, R.sup.5 and n are defined below, which are inhibitors of the production of leukotrienes and/or blockers of leukotriene receptors, methods for preparing said compounds and intermediates useful in the preparation thereof, pharmaceutical compositions thereof methods of treatment therewith. The compounds of the above formula are useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction and related diseases in mammals.
该公式化合物##STR1##及其药学上可接受的盐和前药,其中X.sup.1、Ar、X、Y.sup.1、R.sup.1、R.sup.2、R.sup.3、R.sup.5和n的定义如下,它们是白三烯产生的抑制剂和/或白三烯受体的阻断剂,制备这些化合物的方法及制备中有用的中间体,这些化合物的药物组成物及治疗方法。上述公式的化合物在哺乳动物中预防或治疗哮喘、关节炎、牛皮癣、溃疡、心肌梗死及相关疾病中是有用的。